Does DOXORUBICIN Cause Diffuse large b-cell lymphoma recurrent? 953 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 953 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 1.2% of all adverse event reports for DOXORUBICIN.
953
Reports of Diffuse large b-cell lymphoma recurrent with DOXORUBICIN
1.2%
of all DOXORUBICIN reports
138
Deaths
157
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From DOXORUBICIN?
Of the 953 reports, 138 (14.5%) resulted in death, 157 (16.5%) required hospitalization, and 70 (7.3%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 953 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
BENDAMUSTINE (255)
Which DOXORUBICIN Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE